Applying physical science techniques and CERN technology to an unsolved problem in radiation treatment for cancer: the multidisciplinary ‘VoxTox’ research programme
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Article
Change log
Authors
Abstract
The VoxTox research programme has applied expertise from the physical sciences to the problem of radiotherapy toxicity, bringing together expertise from engineering, mathematics, high energy physics (including the Large Hadron Collider), medical physics and radiation oncology. In our initial cohort of 109 men treated with curative radiotherapy for prostate cancer, daily image guidance computed tomography (CT) scans have been used to calculate delivered dose to the rectum, as distinct from planned dose, using an automated approach. Clinical toxicity data have been collected, allowing us to address the hypothesis that delivered dose provides a better predictor of toxicity than planned dose.
Description
Keywords
multidisciplinary, physical sciences, radiation toxicity
Journal Title
CERN IdeaSquare Journal of Experimental Innovation
Conference Name
Journal ISSN
2413-9505
2413-9505
2413-9505
Volume Title
1
Publisher
CERN Publishing
Publisher DOI
Sponsorship
Science and Technology Facilities Council (ST/M007227/1)
Addenbrooke's Charitable Trust (ACT) (24/15 A/Noble)
Cancer Research UK (C20/A20917)
Cancer Research Uk (None)
Science and Technology Facilities Council (ST/N000234/1)
Science and Technology Facilities Council (ST/I004297/1)
Addenbrooke's Charitable Trust (ACT) (24/15 A/Noble)
Cancer Research UK (C20/A20917)
Cancer Research Uk (None)
Science and Technology Facilities Council (ST/N000234/1)
Science and Technology Facilities Council (ST/I004297/1)
JES was supported by Cancer Research UK through the Cambridge Cancer Centre. NGB, ASP and MG are supported by the National Institute of Health Research Cambridge Biomedical Research Centre. KH, MR AMB, EW and SJB were supported by the VoxTox Research Programme, funded by Cancer Research UK. DJN is supported by Addenbrooke’s Charitable Trust and Cancer Research UK through the Cambridge Cancer Centre. FMB was supported by the Science and Technology Facilities Council. MPDS was part supported by the VoxTox Research Programme, funded by Cancer Research UK. RJ was part supported by the VoxTox Research Programme, funded by Cancer Research UK. LS is supported by the Armstrong Trust. XC was supported by the Isaac Newton Trust. CBS acknowledges support from the EPSRC Centre for Mathematical and Statistical Analysis of Multimodal Clinical Imaging, the Leverhulme Trust, the EU-RISE project CHiPS and the Cantab Capital Institute for the Mathematics of Information. NT was supported by a Gates-Cambridge Scholarship, funded by the Bill and Melinda Gates Foundation, PLY and SYKS by the Singapore Government.